SEP 21, 2026 · JOURNAL ARTICLE
Integrating Germline and Somatic Pharmacogenomics to Predict Tamoxifen Response in Breast Cancer
Obm Genetics
Tamoxifen remains a cornerstone in the treatment of estrogen receptor-positive (ER+) breast cancer; however, variability in patient response underscores the necessity of a pharmaco